SCHEMBL7589488

SCHEMBL7589488

Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCCC(C(=O)NC2CC2)C1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 9/20 0.69
FGFR1 P11362 8/20 0.69
MET P08581 7/20 0.69
PDGFRB P09619 7/20 0.69
SRC P12931 6/20 0.69
EGFR P00533 3/20 0.69
CDK2 P24941 2/20 0.69
PTK2B Q14289 2/20 0.69
MEN1 O00255 2/20 0.69
KMT2A Q03164 2/20 0.69
TDP1 Q9NUW8 2/20 0.69
LCK P06239 2/20 0.69
YES1 P07947 2/20 0.69
KIT P10721 2/20 0.69
NEK2 P51955 2/20 0.69
PLK4 O00444 1/20 0.69
RIOK3 O14730 1/20 0.69
CASK O14936 1/20 0.69
GAK O14976 1/20 0.69
DCLK1 O15075 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL147155 1.00 KDR (0.69) KDRFGFR1METPDGFRBSRC
SCHEMBL146781 0.91 SRC (0.59) KDRFGFR1METPDGFRBSRC
SCHEMBL142964 0.90 KDR (0.69) KDRFGFR1METPDGFRBSRC
SCHEMBL144929 0.88 KDR (0.70) KDRFGFR1METPDGFRBSRC
SCHEMBL147361 0.87 KDR (0.72) KDRFGFR1METPDGFRBSRC
SCHEMBL142239 0.87 KDR (0.80) KDRFGFR1METPDGFRBSRC
SCHEMBL7122491 0.86 KDR (0.79) KDRFGFR1METPDGFRBSRC
SCHEMBL141560 0.86 KDR (0.70) KDRFGFR1METPDGFRBSRC
SCHEMBL144212 0.86 KDR (0.70) KDRFGFR1METPDGFRBSRC
SCHEMBL143746 0.86 KDR (0.67) KDRFGFR1METPDGFRBSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002096361-A2 5-ARALKYLSULFONYL-3- (PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES AS KINASE INHIBITORS SUGEN, INC. (US) 2002-12-05 WO disclosed